Gwen Watanabe is VP of Global Corporate Development & Strategy and on the Executive Committee at Teleflex Inc. She recently led the $1B acquisition of Vascular Solutions which closed in Feb of this year. Watanabe joined Teleflex in July of 2012 as the VP of Hotspur – Cardiac Care through the acquisition of Hotspur Technologies, Inc. At Hotspur, she served as President & CEO since March 2009.Prior to joining Teleflex, she worked in the medical device industry for 18+ years. Watanabe was a founding leader in 3 medical device start-ups: AneuRx (acquired by Medtronic); Bacchus Vascular (acquired by Covidien); and Nellix Endovascular (acquired by Endologix).Watanabe held prior responsibilities within the private equity sector, specifically in medical device venture capital, and she served on several medical device company Board of Directors. Watanabe holds a MBA from Harvard, M.S Mechanical Engineering in the BioMechanics Design from Stanford, and a B.S. Mechanical Engineering from MIT.